Novo Nordisk Cuts Wegovy Price, Eyes Oral Pill Launch
Novo Nordisk reduces Wegovy's price to $349 and prepares an aggressive launch for its oral weight-loss pill to combat competition from Eli Lilly and expand patient access.
Novo Nordisk reduces Wegovy's price to $349 and prepares an aggressive launch for its oral weight-loss pill to combat competition from Eli Lilly and expand patient access.
Novo Nordisk reduces Wegovy price by 37% in India, intensifying the weight loss drug war with Eli Lilly's Mounjaro. Discover the new costs and market impact.
Novo Nordisk reduces its weight loss drug Wegovy's price by 37% in India, intensifying competition with Eli Lilly's Mounjaro. Get the latest details on the new pricing and market dynamics.
Novo Nordisk reduces Wegovy's price by 37% in India as it faces patent loss and competition from Eli Lilly's Mounjaro and upcoming generic versions. Discover the new costs.
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.
In a major breakthrough for weight management, the White House has secured a deal that significantly reduces prices of popular drugs Ozempic and Wegovy, making effective weight loss treatment more accessible across India.
Discover how revolutionary GLP-1 medications including Ozempic, Wegovy, and Mounjaro are transforming America's battle against obesity, offering new hope for sustainable weight loss.
Groundbreaking research shows popular weight-loss drug semaglutide significantly reduces heart disease risk, offering dual benefits for patients struggling with obesity and cardiovascular health.
Danish pharma giant Novo Nordisk, the company behind diabetes & weight-loss blockbusters Ozempic and Wegovy, announces a major boardroom reshuffle. Get the inside scoop on the new faces and strategic direction.